Published in J Acquir Immune Defic Syndr on June 01, 2016
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet (2008) 12.35
Barriers to use of free antiretroviral therapy in injection drug users. JAMA (1998) 6.67
Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med (2007) 6.30
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med (2011) 4.68
Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women. AIDS Behav (2006) 4.34
Neighborhood disadvantage, stress, and drug use among adults. J Health Soc Behav (2001) 4.13
Years of potential life lost (YPLL)--what does it measure? Epidemiology (1990) 3.23
Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep (2002) 3.14
Projected life expectancy of people with HIV according to timing of diagnosis. AIDS (2012) 3.09
Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS (2010) 2.98
The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population. AIDS Patient Care STDS (2007) 2.98
Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs (2006) 2.89
Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med (2013) 2.60
Using surveillance data to monitor trends in the AIDS epidemic. Stat Med (1998) 2.58
Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds. Br J Cancer (2005) 2.54
Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis (2012) 2.39
Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep (2008) 2.32
Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr (2010) 2.21
Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort. Clin Infect Dis (2011) 2.20
Addressing social determinants of health in the prevention and control of HIV/AIDS, viral hepatitis, sexually transmitted infections, and tuberculosis. Public Health Rep (2010) 2.17
Neighborhood socioeconomic status, personal network attributes, and use of heroin and cocaine. Am J Prev Med (2007) 1.99
Prevalence of Diagnosed and Undiagnosed HIV Infection--United States, 2008-2012. MMWR Morb Mortal Wkly Rep (2015) 1.99
United States life tables, 2010. Natl Vital Stat Rep (2014) 1.84
Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis (2001) 1.77
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS (2015) 1.44
Identifying the impact of social determinants of health on disease rates using correlation analysis of area-based summary information. Public Health Rep (2011) 1.13
Recent developments in HIV and the kidney. Curr Opin Infect Dis (2009) 1.06
HIV-associated vascular diseases: structural and functional changes, clinical implications. Int J Cardiol (2009) 0.94
Health service barriers to HIV testing and counseling among pregnant women attending Antenatal Clinic; a cross-sectional study. BMC Health Serv Res (2014) 0.91
HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts. Front Public Health (2014) 0.88
Survival of AIDS patients in Sao Paulo-Brazil in the pre- and post-HAART eras: a cohort study. BMC Infect Dis (2014) 0.83
Life expectancy after HIV diagnosis based on data from the counseling center for behavioral diseases. J Res Med Sci (2013) 0.80
HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics. Epidemiol Infect (2014) 0.77
Risk factors for early mortality after AIDS in the cART era: A population-based cohort study in Italy. BMC Infect Dis (2015) 0.77
Estimation of HIV incidence in the United States. JAMA (2008) 21.27
Estimated HIV incidence in the United States, 2006-2009. PLoS One (2011) 13.03
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr (2010) 4.32
Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011. MMWR Morb Mortal Wkly Rep (2014) 3.60
Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med (2008) 2.90
Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS (2010) 2.62
Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep (2008) 2.32
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31
Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr (2010) 2.21
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Uncertainties associated with incidence estimates of HIV/AIDS diagnoses adjusted for reporting delay and risk redistribution. Stat Med (2005) 2.15
Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition - United States, 2015. MMWR Morb Mortal Wkly Rep (2015) 2.05
Prevalence of Diagnosed and Undiagnosed HIV Infection--United States, 2008-2012. MMWR Morb Mortal Wkly Rep (2015) 1.99
Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999. Cancer (2002) 1.93
Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control (2003) 1.85
Characteristics of HIV infection among Hispanics, United States 2003-2006. J Acquir Immune Defic Syndr (2008) 1.79
HIV in persons born outside the United States, 2007-2010. JAMA (2012) 1.77
Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males. PLoS One (2010) 1.77
Updated annual HIV transmission rates in the United States, 1977-2006. J Acquir Immune Defic Syndr (2009) 1.76
Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: review from national surveys and case studies of 3 states. J Am Acad Dermatol (2011) 1.70
Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004. Am J Public Health (2006) 1.66
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS One (2013) 1.61
Epidemiology of HIV in the United States. J Acquir Immune Defic Syndr (2010) 1.58
Epidemiologic differences between native-born and foreign-born black people diagnosed with HIV infection in 33 U.S. states, 2001-2007. Public Health Rep (2010) 1.52
Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004. PLoS One (2009) 1.48
Racial/ethnic disparities in HIV diagnoses among persons aged 50 years and older in 37 US States, 2005-2008. Am J Public Health (2012) 1.44
Progress along the continuum of HIV care among blacks with diagnosed HIV- United States, 2010. MMWR Morb Mortal Wkly Rep (2014) 1.43
HIV diagnoses and prevalence in the southern region of the United States, 2007-2010. J Community Health (2013) 1.42
Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis (2003) 1.35
Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States. J Acquir Immune Defic Syndr (2014) 1.33
Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med (2004) 1.28
The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev (2013) 1.27
Assessing the completeness of reporting of human immunodeficiency virus diagnoses in 2002-2003: capture-recapture methods. Am J Epidemiol (2006) 1.27
Using the HIV surveillance system to monitor the National HIV/AIDS Strategy. Am J Public Health (2012) 1.27
Collection of social determinant of health measures in U.S. national surveillance systems for HIV, viral hepatitis, STDs, and TB. Public Health Rep (2011) 1.25
Sunburn prevalence among adults in the United States, 1999. Am J Prev Med (2002) 1.22
Men living with diagnosed HIV who have sex with men: progress along the continuum of HIV care--United States, 2010. MMWR Morb Mortal Wkly Rep (2014) 1.21
HIV Diagnoses, Prevalence and Outcomes in Nine Southern States. J Community Health (2015) 1.18
Identifying the impact of social determinants of health on disease rates using correlation analysis of area-based summary information. Public Health Rep (2011) 1.13
Epidemiology of HIV/AIDS among Asians and Pacific Islanders in the United States. AIDS Educ Prev (2005) 1.12
HIV viral suppression among persons with varying levels of engagement in HIV medical care, 19 US jurisdictions. J Acquir Immune Defic Syndr (2014) 1.12
Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am J Obstet Gynecol (2007) 1.11
Hispanics or Latinos living with diagnosed HIV: progress along the continuum of HIV care - United States, 2010. MMWR Morb Mortal Wkly Rep (2014) 1.10
Prokaryotic communities in pit mud from different-aged cellars used for the production of Chinese strong-flavored liquor. Appl Environ Microbiol (2014) 1.09
Using Molecular HIV Surveillance Data to Understand Transmission Between Subpopulations in the United States. J Acquir Immune Defic Syndr (2015) 1.09
Trends in Diseases Reported on US Death Certificates That Mentioned HIV Infection, 1996-2006. J Int Assoc Physicians AIDS Care (Chic) (2010) 1.07
County-level socioeconomic status and survival after HIV diagnosis, United States. Ann Epidemiol (2008) 1.04
Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of Undiagnosed Infections in the United States. J Acquir Immune Defic Syndr (2017) 1.03
Colorectal carcinoma mortality among Appalachian men and women, 1969-1999. Cancer (2004) 1.02
Increases in HIV diagnoses at the U.S.-Mexico border, 2003-2006. AIDS Educ Prev (2009) 1.02
HIV infection - United States, 2008 and 2010. MMWR Surveill Summ (2013) 1.02
Diagnoses of HIV infection among Hispanics/Latinos in 40 states and Puerto Rico, 2006-2009. J Acquir Immune Defic Syndr (2012) 1.00
Use of HIV case surveillance system to design and evaluate site-randomized interventions in an HIV prevention study: HPTN 065. Open AIDS J (2012) 1.00
Electrochemical preparation of silicon and its alloys from solid oxides in molten calcium chloride. Angew Chem Int Ed Engl (2004) 0.99
Caveolin-1 enhances tissue factor pathway inhibitor exposure and function on the cell surface. J Biol Chem (2005) 0.95
Racial disparity in U.S. diagnoses of acquired immune deficiency syndrome, 2000-2009. Am J Prev Med (2012) 0.95
Case-control study evaluating the homogeneity and heterogeneity of risk factors between sinonasal and nasopharyngeal cancers. Int J Cancer (2002) 0.94
Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS strategy in the United States: a closing window for success? AIDS Behav (2012) 0.93
Occupational risk factors for selected cancers among African American and White men in the United States. Am J Public Health (2003) 0.93
Medical costs averted by HIV prevention efforts in the United States, 1991-2006. J Acquir Immune Defic Syndr (2010) 0.93
HIV Transmission Rates in the United States, 2006-2008. Open AIDS J (2012) 0.93
Behavioral factors in assessing impact of HIV treatment as prevention. AIDS Behav (2012) 0.91
HIV diagnoses among men who have sex with men and women-United States and 6 dependent areas, 2008-2011. Am J Public Health (2014) 0.90
Describing the HIV/AIDS epidemic: using HIV case data in addition to AIDS case reporting. Ann Epidemiol (2005) 0.90
Mortality among blacks or African Americans with HIV infection--United States, 2008-2012. MMWR Morb Mortal Wkly Rep (2015) 0.87
Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDS. PLoS One (2013) 0.87
HIV screening practices and hospital characteristics in the US, 2009-2010. Public Health Rep (2013) 0.87
HIV among Haitian-born persons in the United States, 1985-2007. AIDS (2010) 0.86
Disparities in Consistent Retention in HIV Care - 11 States and the District of Columbia, 2011-2013. MMWR Morb Mortal Wkly Rep (2016) 0.86
[Blood lead level of children in the urban areas in China]. Zhonghua Liu Xing Bing Xue Za Zhi (2002) 0.85
Brief report: Time from infection with the human immunodeficiency virus to diagnosis, United States. J Acquir Immune Defic Syndr (2015) 0.85
The Importance of Population Denominators for High-Impact Public Health for Marginalized Populations. JMIR Public Health Surveill (2016) 0.83
Molecular analysis allows inference into HIV transmission among young men who have sex with men in the United States. AIDS (2015) 0.83
Cancers attributable to infections among adults with HIV in the United States. AIDS (2015) 0.82
Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression. AIDS Res Hum Retroviruses (2005) 0.82
HIV Infection and Linkage to HIV-Related Medical Care in Large Urban Areas in the United States, 2009. J Acquir Immune Defic Syndr (2015) 0.81
Diagnoses and Prevalence of HIV Infection Among Hispanics or Latinos - United States, 2008-2013. MMWR Morb Mortal Wkly Rep (2015) 0.81
Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002. Clin Infect Dis (2005) 0.81
Cigarette smoking and risk of Hodgkin's disease: a population-based case-control study. Am J Epidemiol (2002) 0.81